Highlights Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-15 am EDT			5-day change	1st Jan Change
4,159 ^JPY	-1.09%		+2.62%	+2.59%

May. 14	FDA extends review of Ascendis Pharma's hormone disorder therapy	RE
May. 14	Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FDA extends review of Ascendis Pharma's hormone disorder therapy	May. 14	RE
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute	May. 14	MT
Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute	May. 14	MT
Sector Update: Health Care Stocks Mixed Late Afternoon	May. 13	MT
Sector Update: Health Care	May. 13	MT
Top Midday Gainers	May. 13	MT
AC Immune Enters Licensing Deal for Alzheimer's Disease Drug Candidate	May. 13	MT
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate	May. 13	MT
AC Immunity Shares Soar on Exclusive License Deal with Takeda	May. 13	DJ
Takeda Pharmaceutical's Attributable Profit Falls 55% in Fiscal 2024	May. 09	MT
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup	May. 09	DJ
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	May. 09	MT
Takeda Pharmaceutical's Fiscal Q1 Core Earnings Decline, Revenue Increases; Fiscal 2024 Outlook Issued	May. 09	MT
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss -- Update	May. 09	DJ
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss	May. 09	DJ
Japan's Takeda Pharma says full-year profit slumps 56%	May. 09	RE
Takeda Pharmaceutical Company Limited Provides Earnings Guidance for the Full Year of 2024	May. 09	CI
Takeda Pharmaceutical Company Limited Declares Dividend for the Year Ended March 31, 2024, Payable June 27, 2024; Provides Dividend Guidance for the Second Quarter-End and Year-End of Fiscal Year Ending March 31, 2025	May. 09	CI
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	Apr. 30	RE
EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug	Apr. 26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Takeda Pharmaceutical Company Limited

Equities

4502

JP3463000004

Highlights

Filters